These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report. Faust AC; Peterson EJ J Emerg Med; 2014 Apr; 46(4):525-9. PubMed ID: 24508114 [TBL] [Abstract][Full Text] [Related]
4. Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study. Sølbeck S; Nilsson CU; Engström M; Ostrowski SR; Johansson PI Scand J Clin Lab Invest; 2014 Oct; 74(7):591-8. PubMed ID: 24909158 [TBL] [Abstract][Full Text] [Related]
5. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity. Dager WE; Gosselin RC; Roberts AJ Crit Care Med; 2013 May; 41(5):e42-6. PubMed ID: 23474679 [TBL] [Abstract][Full Text] [Related]
6. Management of dabigatran-induced anticoagulation in trauma and acute care surgery patients. Obeng-Gyasi S; Loor MM; Samotowka MA; Moorman ML J Trauma Acute Care Surg; 2012 Nov; 73(5):1064-9. PubMed ID: 23117369 [No Abstract] [Full Text] [Related]
7. Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran. Getta B; Muller N; Motum P; Hsu D; Zebeljan D; Rosenfeld D Br J Haematol; 2015 May; 169(4):603-4. PubMed ID: 25425051 [No Abstract] [Full Text] [Related]
8. Hemorrhagic complications associated with dabigatran use. Chen BC; Viny AD; Garlich FM; Basciano P; Howland MA; Smith SW; Hoffman RS; Nelson LS Clin Toxicol (Phila); 2012 Nov; 50(9):854-7. PubMed ID: 22970730 [TBL] [Abstract][Full Text] [Related]
9. Bleeding risk with dabigatran in the frail elderly. Harper P; Young L; Merriman E N Engl J Med; 2012 Mar; 366(9):864-6. PubMed ID: 22375994 [No Abstract] [Full Text] [Related]
10. When dabigatran and trauma collide. Huang GS; Chance EA Am Surg; 2013 Jan; 79(1):113-4. PubMed ID: 23317625 [No Abstract] [Full Text] [Related]
11. Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department. Díaz MQ; Borobia AM; Núñez MA; Virto AM; Fabra S; Casado MS; García-Erce JA; Samama CM Haematologica; 2013 Nov; 98(11):e143-4. PubMed ID: 24186317 [No Abstract] [Full Text] [Related]
12. Dabigatran and bleeding: still an emergent situation? Van Heukelom J; Lal Y Am J Med Sci; 2013 Sep; 346(3):259. PubMed ID: 23698156 [No Abstract] [Full Text] [Related]
13. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Lillo-Le Louët A; Wolf M; Soufir L; Galbois A; Dumenil AS; Offenstadt G; Samama MM Thromb Haemost; 2012 Sep; 108(3):583-5. PubMed ID: 22782645 [No Abstract] [Full Text] [Related]
14. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P; Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130 [TBL] [Abstract][Full Text] [Related]
15. Dabigatran, bleeding, and the regulators. Moore TJ; Cohen MR; Mattison DR BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265 [No Abstract] [Full Text] [Related]
16. [Dabigatran and emergency operation on a peritonitis patient]. Ilmakunnas M; Louhimo J; Lassila R Duodecim; 2012; 128(7):753-7. PubMed ID: 22612026 [TBL] [Abstract][Full Text] [Related]
17. Reversal of a dabigatran overdose: what are possible options? Ratanapo S; Ungprasert P; Srivali N; Cheungpasitporn W; Bischof EF Am J Med Sci; 2013 Sep; 346(3):259. PubMed ID: 23974270 [No Abstract] [Full Text] [Related]
18. [Dabigatran therapy--perioperative management and interpretation of coagulation tests]. Spannagl M; Bauersachs R; Debus ES; Gawaz M; Gerlach H; Haas S; Hach-Wunderle V; Lindhoff-Last E; Riess H; Schellong S; Schinzel H; Bode C Hamostaseologie; 2012; 32(4):294-305. PubMed ID: 23114798 [TBL] [Abstract][Full Text] [Related]
20. Dabigatran: how the drug company withheld important analyses. Cohen D BMJ; 2014 Jul; 349():g4670. PubMed ID: 25055829 [No Abstract] [Full Text] [Related] [Next] [New Search]